Compliance spectrum as a drug fingerprint of drug intake and drug disposition.

about

Variability and singularity arising from poor compliance in a pharmacokinetic model II: the multi-oral case.

P2860

Q48154210-CAC12486-1273-477E-B387-F711889A108D

P2860

Compliance spectrum as a drug fingerprint of drug intake and drug disposition.

Item

http://www.wikidata.org/entity/Q51286554

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Compliance spectrum as a drug fingerprint of drug intake and drug disposition.

@en

Compliance spectrum as a drug fingerprint of drug intake and drug disposition.

@nl

type

Item

label

Compliance spectrum as a drug fingerprint of drug intake and drug disposition.

@en

Compliance spectrum as a drug fingerprint of drug intake and drug disposition.

@nl

prefLabel

Compliance spectrum as a drug fingerprint of drug intake and drug disposition.

@en

Compliance spectrum as a drug fingerprint of drug intake and drug disposition.

@nl

P1476

Compliance spectrum as a drug fingerprint of drug intake and drug disposition.

@en

P2093

Fahima Nekka

http://www.w3.org/2001/XMLSchema#string

Jun Li

http://www.w3.org/2001/XMLSchema#string

P2860

Estimating treatment effect in the presence of non-compliance measured with error: precision and robustness of data analysis methods.

Prediction of diltiazem plasma concentration curves from limited measurements using compliance data.

Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models.

Performance of Cpred/Cobs concentration ratios as a metric reflecting adherence to antidepressant drug therapy.

Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein.

Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories.

A Markov mixed effect regression model for drug compliance.

A probabilistic approach for the evaluation of pharmacological effect induced by patient irregular drug intake.

Estimation of population pharmacokinetic parameters in the presence of non-compliance.

Modelling the association between adherence and viral load in HIV-infected patients.

P2888

s10928-012-9285-x

P304

41-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10928-012-9285-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Olivier Barrière

P577

2012-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23250805

http://www.w3.org/2001/XMLSchema#string

Compliance spectrum as a drug fingerprint of drug intake and drug disposition.

about

P2860

P2860

Compliance spectrum as a drug fingerprint of drug intake and drug disposition.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698